Hong Kong vaccination drive struggles to gain public trust
HONG KONG (AP) — Hong Kong’s sudden suspension of a COVID-19 vaccine developed by Pfizer and BioNTech is another blow to a vaccination program already struggling against a wall of public distrust.
Hong Kong on Wednesday suspended use of the Pfizer vaccine, distributed by Chinese pharmaceutical firm Fosun Pharma, after defective packaging such as loose vial lids and cracks on bottles were found in one of two batches of the vaccine.